Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/21/15 → 12/21/20 |
Funding
- Quintiles, Inc. (Prot #GA28951)
- Genentech, Inc. (Prot #GA28951)
Prot #GA28951: An Open Label Extension And Safety Monitoring Study Of Moderate To Severe Ulcerative Colitis Patients Previously Enrolled In Etrolizumab Phase III Studies
- Hanauer, stephen B (PD/PI)
Project: Research project